4A.07: PREVALENCE AND RISK FACTORS FOR REFRACTORY HYPERTENSION IN THE DENERHTN STUDY.

Objective:The French DENERHTN trial has shown that renal denervation (RDN, Symplicity Catheter) in addition to standardized optimal medical treatment (SOMT) decreases ambulatory BP more (6 mmHg) than the same SOMT alone at 6 months in patients (pts) with resistant hypertension (RH). However, some pt